Download Free Sample Report

The global Trastuzumab Injection market was valued at US$ 1286.2 million in 2023 and is projected to reach US$ 1818.5 million by 2030, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
60 mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab Injection include Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca and Remegen Co., Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Trastuzumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Injection. This report contains market size and forecasts of Trastuzumab Injection in global, including the following market information:

• Global Trastuzumab Injection Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Trastuzumab Injection Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Trastuzumab Injection companies in 2023 (%)

We surveyed the Trastuzumab Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Injection Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Trastuzumab Injection Market Segment Percentages, by Type, 2023 (%)

• 60 mg
• 150 mg
• 440 mg
• Others

Global Trastuzumab Injection Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Trastuzumab Injection Market Segment Percentages, by Application, 2023 (%)

• Hospitals
• Clinics
• Others

Global Trastuzumab Injection Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Trastuzumab Injection Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Trastuzumab Injection revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Trastuzumab Injection revenues share in global market, 2023 (%)
• Key companies Trastuzumab Injection sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Trastuzumab Injection sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Roche
• Celltrion
• Amgen
• Samsung Bioepsis
• Mylan
• Glenmark
• AstraZeneca
• Remegen Co., Ltd.
• Hisun Biopharmaceutical
• Shanghai Henlius Biotech

Outline of Major Chapters:
Chapter 1: Introduces the definition of Trastuzumab Injection, market overview.
Chapter 2: Global Trastuzumab Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Trastuzumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trastuzumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Trastuzumab Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.